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Abstract
A growing number of studies are evaluating retinal progenitor cell (RPC) transplantation as an approach to repair
retinal degeneration and restore visual function. To advance cell-replacement strategies for a practical retinal
therapy, it is important to define the molecular and biochemical mechanisms guiding RPC motility. We have analyzed
RPC expression of the epidermal growth factor receptor (EGFR) and evaluated whether exposure to epidermal
growth factor (EGF) can coordinate motogenic activity in vitro. Using Boyden chamber analysis as an initial high-
throughput screen, we determined that RPC motility was optimally stimulated by EGF concentrations in the range of
20-400ng/ml, with decreased stimulation at higher concentrations, suggesting concentration-dependence of EGF-
induced motility. Using bioinformatics analysis of the EGF ligand in a retina-specific gene network pathway, we
predicted a chemotactic function for EGF involving the MAPK and JAK-STAT intracellular signaling pathways. Based
on targeted inhibition studies, we show that ligand binding, phosphorylation of EGFR and activation of the
intracellular STAT3 and PI3kinase signaling pathways are necessary to drive RPC motility. Using engineered
microfluidic devices to generate quantifiable steady-state gradients of EGF coupled with live-cell tracking, we
analyzed the dynamics of individual RPC motility. Microfluidic analysis, including center of mass and maximum
accumulated distance, revealed that EGF induced motility is chemokinetic with optimal activity observed in response
to low concentration gradients. Our combined results show that EGFR expressing RPCs exhibit enhanced
chemokinetic motility in the presence of low nanomole levels of EGF. These findings may serve to inform further
studies evaluating the extent to which EGFR activity, in response to endogenous ligand, drives motility and migration
of RPCs in retinal transplantation paradigms.
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Introduction
The loss of retinal tissue due to trauma or disease such as
age-related macular degeneration (AMD) remains a tragic and
largely untreatable problem. More than 1.6 million Americans
have AMD [1]. In cases of significant loss of neural retina there
is permanent vision loss with no available restorative treatment.
Cell replacement strategies for retinal tissue have been shown
to be feasible in animal models using retinal progenitor cells
(RPCs) derived from embryonic stem cells (ESCs), neural
progenitor cells (NPCs), induced pluripotent stem cells (iPSCs),
or early postnatal retina [2,3]. Current retinal transplantation
paradigms utilize either bolus injection or delivery of new cells
on biodegradable substrates [4-7]. For restoration of retinal
architecture and visual function, transplanted RPCs have to
migrate from the point of transplantation, commonly the sub-
retinal space, through the interphotoreceptor matrix (IPM) to
integrate into appropriate lamina [3,8,9]. Unfortunately, the
migration of transplanted RPCs in retinal tissue is limited in
both healthy/control and diseased retina [5-7,10]. Restricted
retinal migration has been shown for RPCs isolated from retina
[5,11,12] and photoreceptor progenitors derived from ES and
iPSCs in vitro prior to transplantation [13]. The molecular and
biochemical mechanisms underlying the migration of
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transplanted RPCs to retinal lamina are poorly understood.
Identified barriers to RPC migration and integration include a
meshwork of chondroitin sulfate proteoglycans in the IPM,
inhibitory extracellular matrix (ECM) molecules and obstructive
microglial accumulation [14]. Progenitors can dissolve the ECM
by releasing matrix metalloproteinases and experimental
disruption of structural barriers can modestly enhance RPC
integration [4,15,16]. In this study, we begin the process of
delineating RPC surface receptors and endogenous
extracellular factors capable of enhancing the directed motility
of transplanted RPCs. The characterization of molecular
mechanisms and biochemical compounds capable of guiding
successful migration of RPCs in the retina is essential for
increasing the efficacy of future transplantation strategies.
In adult human and mouse retina, constitutive expression of
the EGFR has been observed in ganglion, amacrine and
horizontal cells, and synaptic regions of photoreceptors [17-19].
Increased EGFR expression has been described in human
retina during proliferative diabetic retinopathy [20]. Adult human
and mouse retinal ganglion cells have been shown to
transcribe EGF mRNA [18,19]. In addition, in damaged retina,
Muller glia up-regulate synthesis of EGF to levels similar to
those driving histogenesis during development [17].
The activation of EGFR has been associated with the
proliferation and motility of RPCs, a range of neural progenitors
[17,21-24] and retinal pigment epithelial cells [25]. RPCs
transplanted into adult retina are localized to a region of
interphotoreceptor matrix, photoreceptor outer segments and
Muller glia end-feet [26]. As ganglion and Muller glia have been
shown to synthesize EGF, it is plausible that a chemotactic
gradient of EGF is established, influencing migration of EGFR-
expressing RPCs. Growth factor gradients have previously
been shown to stimulate proliferation and motility of neural
progenitors [27], connective tissue-derived cells [28], and
cancer cells [29,30] and are utilized in many related biological
applications [31]. To determine the role of EGF gradients on
RPC motility, steady-state nanomolar level gradients of EGF
were generated in this study using a bioengineered microfluidic
system [32].
For cell motility to be elicited, EGF binds to its receptor on
the plasma membrane, induces dimerization of EGFR which
activates its tyrosine kinase, auto-phosphorylation and/or
internalization of receptor-ligand complexes [33]. Mediators
such as phospholipase C-γ1 (PLC-γ1), focal adhesion kinase
(FAK) and Rho-GTPases signal canonical downstream
pathways including the PI3Kinase [24] and MAPK signaling
pathways [34] responsible for disruption of focal adhesions and
stimulation of cytoskeletal reorganization to facilitate cell
motility [35-37].
In this work, we used bioinformatics to map intracellular EGF
signaling pathways in RPCs, selectively inhibited resolved
pathway molecules, and evaluated their influence on motility.
Bioinformatics-modeled gene networks have previously been
shown to successfully predict and target molecular interactions
in vitro and in vivo [38,39]. Here, RPC migratory dynamics
were analyzed in response to nanomolar EGF concentrations
alone and in the presence of pharmacologic modulators of
genetic pathways [40]. Stimulation and inhibition parameters
were initially screened using high-throughput Boyden assays.
In the presence of optimized exposure time and concentration
parameters, individual RPC migratory dynamics were analyzed
in bioengineered microfluidic devices with defined quantifiable
EGF gradients. Our results show that low nanomole EGF
concentration ranges stimulate activity of JAK-STAT and PI3K
pathways resulting in increased chemokinesis of RPCs. The
results shown in this study further our understanding of
molecular and biochemical interactions necessary for RPC
motility and may help guide the development of optimized cell-
replacement transplantation paradigms.
Materials and Methods
Retinal Progenitor Cell Culture
All experiments were approved by and performed in
compliance with the City University of New York, Lehman
College Animal Care and Use Committee (IACUC). Retinal
progenitor cells (RPCs) were isolated from postnatal day (PN)
0-3 mouse retina and maintained in culture as previously
described [41]. PN 0-3 Beta actin-GFP+ RPCs were cultured in
Neurobasal (NB) complete culture medium containing 2%
B-27, 1% L-glutamine, 1% Pen Strep, 1% N2 (50X), 2%
Nystatin, and 93% NB only (Invitrogen-Gibco, Rockville, MD)
and 20ng/ml epidermal growth factor (Promega, Madison,
Wisconsin). In preparation for experiments, RPCs were rinsed
and cultured without EGF in NB complete culture medium.
RPCs were maintained in 5% CO2 at 37°C during all
experiments.
IPA Bioinformatics Analysis
A signaling interactions network specific for the EGF ligand
was generated using Ingenuity Pathway Analysis (IPA)
(Ingenuity® Systems, www.ingenuity.com, Redwood City, CA)
knowledge base. Complex molecular networks orchestrating
cellular decision-making are guided by changes in intracellular
and extracellular micro-environmental signaling. A major
strength of IPA software is its comprehensive regularly updated
database of experimentally predicted molecular signaling
networks. An increasing number of studies are utilizing IPA
database network analysis to predict cell and tissue specific
signaling interactions [39,42]. In this study, EGF was entered
into the IPA platform as the ligand target. Direct and indirect
molecular interactions associated with EGF were generated
from the IPA network database. Molecules in the network were
further specified for their activity in the mammalian retino-
neural system followed by a functional analysis to identify the
biological functions most relevant to the resulting molecules in
the network. A right-tailed Fisher’s exact test was used to
calculate a p-value determining the probability that each
biological function assigned to that network was due to chance
alone.
Cell Proliferation Assay
A cell proliferation assay (Vybrant MTT, Invitrogen, Grand
Island, NY) was carried out to examine RPC growth in different
EGF concentrations for the same 24hr duration used in cell
Retinal Progenitor Cell Migration in EGF-gradient
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motility experiments. This assay was carried out to ensure that
EGF ligand concentration effects measured were for motility
only, distinguishable from cell proliferation. In n=6 wells per
condition, approximately 5000 RPCs per well were incubated in
NB with 5% CO2 at 37°C overnight in duplicate 96-well culture
plates and in quadruplicate wells/plates. Media was then
aspirated and replaced with 100μl of NB media supplemented
with: 20, 40 and 400ng/ml EGF concentrations. Wells were
incubated for 24hrs, after which 10μl of 10% MTT reagent was
added for 4hrs followed by 100μl of MTT solubilization buffer
overnight. Absorbance was measured at 575nm and 650nm
using a Synergy Mx plate reader (BioTek Instruments Inc.,
Winooski, VT), and results plotted against EGF concentrations
after background correction. Using serial dilution with NB
media, the absorbance of increasing numbers of RPCs ranging
from 1000 to 20000 cells/well, were used to create a standard
curve correlating cell number to absorbance units. Using a
Dunnett statistical test, no significant differences in cell
numbers were observed between control and experimental
conditions (n=6 wells each; mean ± SD): 0ng = 9431.1±
1163.68 (p=1.0000), 20ng = 9219.5 ± 713.36 (p=0.9611), 40ng
= 9388.2 ± 669.46 (p=0.9966) and 400ng= 8779.8 ± 1544.60
(p=0.4956).
Immunocytochemistry
For each antibody evaluated, RPCs were seeded onto n=6
laminin-coated (10µg/mL) coverslips (15mm (19/32”),
Thermoscientific, Rochester NY) at a density of 9,000 to
13,000 cells/cm2 in 6-well culture plates and incubated
overnight at 37°C for immunocytochemical staining using a
previously described protocol [43]. Briefly, adherent cells were
rinsed twice with warm phosphate-buffered saline (PBS) and
fixed for 10mins in 1% paraformaldehyde in PBS. After rinsing
with wash buffer (0.1% BSA in PBS), cells were blocked and
permeabilized for 45 mins by incubation in 0.3% Triton X-100
and 10% normal donkey/rabbit serum (Sigma-Aldrich, St.
Louis, MO). Primary antibodies specific to either total epidermal
growth factor receptor, which labels both phosphorylated and
non-phosphorylated EGFR, (anti-EGFR-total) (1:1000, Sigma-
Aldrich, St. Louis, MO) or phosphorylated epidermal growth
factor (anti-EGFR-phospho) (1:1000, Abcam, Cambridge, MA)
antibodies were used for ICC receptor localization [44,45]
Antibodies were diluted in incubation buffer (1% BSA plus 1%
normal donkey/rabbit serum plus 0.3% Triton X-100 and 0.01%
sodium azide in 1X PBS) and incubated with coverslips
overnight at 4°C. Coverslips with adherent cells (n = 6) per
antibody were then washed thrice (5 min each) with wash
buffer and subsequently incubated with secondary anti-mouse
TritC-conjugated antibody (1:10000; R&D systems,
Minneapolis, MN) for phospho- and total EGFR receptors, for 1
h at room temperature. After rinsing once for 15 min and thrice
for 5 min with wash buffer, cover slips were inverted onto glass
slides coated with DAPI-containing anti-fade mounting medium
(Invitrogen, Grand Island, NY). DAPI-stained nuclei, GFP+ cell
body and TritC-conjugated EGF receptor expression were
assessed on an inverted fluorescent microscope (Nikon Eclipse
Ti, Melville, NY) using 40X and 100X objectives.
Western Blot
Ice cold lysis buffer (0.5ml per 5 X 106 cells) containing:
150mM NaCl, 1% Triton X-100, 50 mM Tris, pH 8.0, 1 mM
phenylmethylsulfonyl fluoride (PMSF, Sigma-Aldrich, P7626),
Halt Protease inhibitor Cocktail (Pierce IL, 78425), and
phosphatase inhibitor (Sigma-Aldrich, P5726), was added to
RPC cultures that had been incubated for 24hrs with 0, 20 and
40ng/ml EGF concentrations. The cell mixture was agitated for
30mins and then centrifuged at 12,000rpm for 20mins at 4°C.
The resulting supernatant was used to determine protein
concentration by the Bradford assay and subsequently, 25-40
µg of protein was separated on 8% SDS-PAGE (Clear Page
Gel, CBS Scientific, San Diego, CA) and then transferred onto
nitrocellulose membranes. The membranes were probed
overnight at 4°C with monoclonal anti-EGFR (Sigma-Aldrich,
St. Louis, MO) and anti-phospho-EGFR (Abcam, Cambridge,
MA), polyclonal anti-ERK1/2 (Santa Cruz Biotech., Dallas, TX),
anti-PI3K, anti-β-tubulin, polyclonal anti-phospho-STAT3 (Cell
Signaling Technology, Danvers, MA), and polyclonal anti-
STAT3 (Calbiochem, Darmstadt, Germany) primary antibodies.
Secondary antibodies conjugated to horse-radish peroxidase
(HRP) (1:10000, Jackson ImmunoResearch, Westgrove, PA)
was bound to the nitrocellulose membranes for 1hr at room
temperature and X-ray detection was carried out after applying
enhanced chemiluminescence substrate mixture (ECL Plus;
Pierce IL) to the membrane. β-tubulin was used to correct for
blotting efficiency and normalization. Similar methods used for
detecting intracellular signaling activity have previously been
described [46].
Boyden Chamber Migration Assay and Motility-
inhibition studies
Initial screening for chemotactic response of RPCs to
epidermal growth factor (EGF) was assessed using the Boyden
chamber assay as previously described [24,46-49]. Cells were
grown in neurobasal (NB) media containing 2% B-27, 1% L-
glutamine, 1% Pen Strep, 1% N2 (50X), 2% Nystatin, and 93%
NB only. RPCs were then re-suspended in NB media complete
supplemented with 10% fetal bovine serum (FBS) and seeded
at a density of 1 X 105 cells in 350µl volumes on the upper
chamber of non-coated polyethylene terephthalate (PET)
membrane filters (8µm pore size, BD Falcon, NJ). These filters
insert into tissue culture wells (BD Falcon, NJ) containing 0
(control), 20, 40 and 400ng/ml EGF diluted in 700µl volumes of
NB media. Boyden chamber incubation period optimization
studies for 6-48hrs were performed using 40ng/ml EGF and
pooled data from N=24 chambers were reported as normalized
mean ± SEM: 6hrs = 0.193 ± 0.05 p=0.6749, 18hrs = 1.29 ±
0.18 p=0.1067, 24hrs = 1.97 ± 0.30 p=0.0026* and 48hrs =
1.87 ± 0.21 p=0.0026*. To ensure optimal ligand stimulation
and cell viability, the 24hr time-point was selected. In the
experiments in which inhibitors to EGFR or selected
intracellular signaling proteins were used, RPCs were pre-
incubated with the inhibitors at 37°C in 5% CO2 before loading
in the upper chamber as has been previously described
[22,24,46]. Inhibitor concentrations and their incubation times
with RPCs in Boyden Chambers included the following: (1)
monoclonal anti-EGFR (100nM, 2hrs, Sigma-Aldrich Co., St.
Retinal Progenitor Cell Migration in EGF-gradient
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Louis, MO), (2) STAT3 inhibitor, AG 490 (5μM, 60mins,
Calbiochem, Darmstadt, Germany), (3) the cell-permeable,
irreversible and selective inhibitor of EGFR tyrosine kinase
activity Tyrphostin AG1478 (200nM, 30mins), (4) ERK1/2
inhibitor PD98059 (10μM, 60mins) and (5) PI3K inhibitor
Wortmanin (250nM, 60mins), all from Cell Signaling
Technology, Danvers, MA. RPCs were then allowed to migrate
for 24hr at 37°C and 5% CO2. Filters were fixed with 4%
paraformaldehyde in PBS for 5 min and stained with DAPI or
Hoechst 33342 nuclear stains for 10 min. Cells are scraped
from the upper chamber, and the number of stained migrated
cells at the bottom surface of the filter were counted at ﬁve
ﬁelds per filter for triplicate filters in two independent
experiments (n=6) using an inverted fluorescent microscope.
Control tissue culture wells contained NB media without any
added chemotactic factor (migration study) or without inhibitors
(inhibition study). A Dunnett statistical test was used to
determine the number of migrated RPCs normalized to cell
migration in control filters. Successful inhibition of RPC
migration was determined by RPC numbers in test wells that
were significantly (p<0.05) less than cell numbers in control
chambers containing no inhibitors.
The Bridged µ-lane Microfluidic System
A micro-fabricated system, bridged μ-lane [32] was utilized to
live-image individual RPC chemotactic responses within
microenvironments that create precise spatial and temporal
profiles of EGF concentration gradients over long distances.
The bridged μ-lane device applies buoyancy-driven forces to
initiate minute convective velocities that assist molecular
diffusion of chemotropic factors. Quantification of ligand mass
transport within the microsystem was solved using finite
element methods (FEMLab Version 3.4, Comsol Inc.,
Burlington, MA). Sequential optical monitoring of individual cell
movement within predictable microenvironments in the device
permitted measurement of mechanistic parameters governing
RPC migration such as polarization, directionality and
chemosensitivity to steady state concentration gradients [50].
Bridged µ-lane Chamber Fabrication
The framework of the bridged μ-lane device consists of two
layers of poly-dimethylsiloxane (PDMS): a closed microchannel
(95-μm-hydraulic diameter: 90μm-depth, 100μm-width; 1.3cm-
length), a source reservoir (SRR) and a sink reservoir (SKR)
(9μl volume each) on the bottom layer, and a source chamber
(SRC) and sink chamber (SKC) (170μl volume each)
connected by an open, hemispherical bridge channel (2-mm-
depth; 9-mm-length). The system is fabricated using
elastomeric molding of the silicon polymer PDMS
(polydimethylsiloxane) and bonding of PDMS to PDMS and
PDMS to glass. The SRC and SKC in the top layer are
vertically and fluidically connected to the SRR and SKR in the
bottom layer, and the bridge channel connects the SRC to the
SKC in order to balance their solution volumes. The complete
bridged μ-lane system is thus composed of the upper user
interface layer with an open bridge channel that connects the
SRC and SKC chambers, as well as a bottom layer closed
microchannel that connects the SRR and SKR reservoirs [32].
The double-layered PDMS is then bonded to chemically
cleaned (Nanostrip, Freemont, CA) glass slides using ozone
gas exposure.
Operation of the Bridged µ-lane System
The bridged μ-lane system works by using the large volume
chambers and bridge channel of the upper user interface layer
to generate concentration gradients within the smaller volume
microchannel on the bottom layer. After incubating cells along
the microchannel, the cell culture media is manually loaded
until it has filled the SRR, microchannel, SKR, SKC, and bridge
channel. The test chemical solution is then loaded drop-wise
into the SRC until the sample makes contact with the solution
within the bridge channel to initiate system operation. The
engineering design of the microchannel allows reagent
perturbations of different concentrations of the test ligand to
drive convective minuscule bulk velocity flow through the
microchannel in the bottom layer, minimizing time required to
attain a steady-state gradient of the ligand [28]. The volume of
each chamber (170μl) is designed to be much larger than the
volume within each reservoir (9μL) and μ-lane (0.1μl), in order
to facilitate manual micropipette loading that initiates gradual
transport into the microchannel with minimal channel entrance
effects. Movement of chemicals from the source to sink
reservoirs generates concentration gradients within the closed
microchannel. Experimental measurement of EGF transport
within this microchannel has previously been carried out and a
diffusivity value of 2 X 10-6cm2/s was resolved for the ligand
[28]. This value was then used to generate concentration
profiles of EGF as a function of time and axial position, and it
was determined that a steady state gradient of EGF was
attained within this microchannel after 18hrs [28].
Microfluidic Assay and Microscopic Imaging
The engineered microfluidic gradient assay adopts a
previously established protocol [28]. The microchannel is
coated with 10μg/mL laminin (Sigma-Aldrich Co., St. Louis,
MO) for 1hr at room temperature. After aspirating excess
unbound laminin, 0.1μl of RPC suspension (1×106 cells/mL) in
NB media supplemented with 10% FBS is then injected into the
microchannel for a 4hr incubation period. The SRC, SKC and
bridged channel are also filled with media. NB media
concentrations containing 0 (control), 20, 40, or 400ng/ml EGF
is then added drop-wise into the SRC till the solution makes
contact with media in the bridge channel. The device is then
mounted on the motorized stage of an inverted microscope
(Nikon TE2000) housed in a humidified incubator (Okolabs,
NA, Italy). The temperature in the incubator is maintained at
37°C with 5% CO2/balanced air supply. Live cell images were
obtained at hourly intervals over 24hrs in three to five
independent experiments per EGF test concentration. Emitted
fluorescence from GFP+-RPCs is detected via a cooled CCD
camera (Cool SNAP EZ, Photometrics, Tucson, AZ) and
collated with Nikon software (Nikon Instrument Element 2.30
with 6D module, Morrell Instrument Co. Inc., Melville, NY).
Retinal Progenitor Cell Migration in EGF-gradient
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Microfluidic Data Analysis
Cell motility parameters of center of mass (COM) and
maximum accumulated distance, for each cell tracked over
24hrs, were resolved via sequential use of Nd-to-Image6d,
Manual Tracking, and Chemotaxis and Migration Tool 2.0 (ibidi,
Verona MI) plug-ins, all running on an ImageJ platform. COM is
a strong parameter for evaluating chemotaxis, and measures
the spatial average displacement of all cell endpoints with
positive or negative coordinates, depending on the direction of
movement of a single cell or a population of cells. Cell tracking
data was further revised to select only video recordings of RPC
movement between 10 and 24hrs to account for periods of
attained steady-state gradients of EGF along the microchannel.
Mean COM and maximum distance accumulated by RPCs
were compared between control and test groups using the
Dunnett statistical test. The Dunnett test was employed as a
conservative statistical measure, appropriate for determining
significant differences between treatment group means and a
control mean rather than a total grand mean, especially when
sample sizes among test groups are similar [51,52].
Results
Interactions of MAPK and JAK/STAT signaling
pathways are predicted to govern EGF-induced RPC
motility
We used bioinformatics analysis to determine the presence
of cell surface receptor and intracellular signaling pathways
capable of driving RPC migration. Figure 1 displays a network
model of direct molecular interactions predicted to be induced
by EGF in mammalian neural retina. Network prediction was
carried out using the pathway designer function of the Ingenuity
Pathway Analysis (IPA) software and molecules relevant to
chemotaxis function were identified by a right-tailed Fisher test
for statistical significance (p=8.67E-10; molecules outlined or
shaded in red). The right-tailed Fisher exact test is appropriate
for bioinformatics data analysis and was used here to calculate
P value to determine if associations between IPA resolved EGF
network molecules and genes involved in chemotaxis were
statistically significant [42,53]. Additional cellular functions
resolved in this analysis included proliferation, cell-to-cell
signaling, gene regulation and cell cycle progression. Our
bioinformatics-derived network model also predicted two
signaling pathways previously shown to be involved in EGF-
induced motility (Figure 1). Activation of phospholipase C-γ1
(PLCG1) and subsequent hydrolysis of phospho-inositide
bisphosphate (PIP) to yield products that activate protein
kinase C (PRKCA) have been shown to increase cytoplasmic
calcium levels which in turn stimulates cytoskeleton
reorganization for cell motility [34,54,55]. PRKCA
phosphorylates Raf1 (MAP kinase kinase kinase (MAP3K))
activating MAPK1/3 signaling [56]. Figure 1 also shows the
coupling of EGFR activation to docking proteins GRB2 (Growth
factor receptor bound)/SOS (Son of sevenless) via their SHC
(Src homology) domain, an interaction that can activate HRas
and its effector, the protein kinase Raf1. Raf can initiate
phosphorylation events that activate the ERK1/2 signaling
pathway leading to disruption of focal adhesions in mouse
fibroblasts, and enhanced membrane ruffling, both essential
processes for cell motility [34,55,57]. The same mechanism
can phosphorylate insulin receptor substrate (IRS) and p85,
which result in the activation of phosphoinositide 3-kinase
(PI3K) [46], identified to be indirectly involved in the model
network (Figure 1). Additionally, RAF1 directly associates with
Janus Kinase (JAK) to activate Signal Transducer and
Activator of transcription (STAT) proteins which can bind
specific nuclear regulatory sequences to activate or repress
transcription of target genes that are involved in cell motility
[56].
Our bioinformatics model predicts a potential cross-
interaction between the JAK/STAT and the EGFR tyrosine
kinase (RTK)/Ras/MAPK pathways (Figure 1). Activated EGFR
has previously been shown to promote JAK-independent
tyrosine phosphorylation of STATs, a process possibly
involving Src kinase [56]. MAPK has also been shown to
specifically phosphorylate a serine residue near the C-terminus
of most STATs as our model predicts. Although this
phosphorylation event dramatically enhances transcriptional
activity of STAT, it is not absolutely required for STAT activity
[56]. Our bioinformatics model suggests that RPC motility
signaling is a tightly regulated event involving a chemotactic
role for EGF and the MAPK and JAK-STAT signaling
pathways, with indirect involvement of the PI3K pathway.
EGF receptor is expressed and localizes to punctate
structures along cellular processes in RPCs exposed to
EGF
To determine the expression and localization of EGFR in
RPCs exposed to EGF, we performed immunofluorescence
analysis of RPCs exposed to EGF. Antibodies recognizing both
total EGFR and a phospho-specific form of EGFR were used
(Figure 2B and 2F, respectively). Our results show that both
non-phosphorylated and phosphorylated forms of EGFR are
present in these RPCs and that the receptors localize
throughout the cell body and also to punctate structures along
cellular processes (Figure 2B,F). EGFR expression appeared
identical between 20, 40 and 400 ng/ml EGF concentrations.
No observable difference was detectable between
experimental conditions for RPCs adherent to coverslips
labeled with anti-total-EGFR and anti-phospho-EGFR. The
labeling of EGFR observed in this work correlates with other
studies showing similar results across a range of high and low
EGF concentrations and in both RPCs and adult retinal cell
types [17,40,58]. For this study, activated EGFRs represent the
requisite cell surface mechanism to activate downstream JAK-
STAT and PI3Kinase pathways involved in RPC motility.
Motility tests support predicted role of JAK-STAT and
PI3Kinase signaling in EGF-induced RPC migration
RPC motility in response to EGF concentrations ranging from
20ng to 400ng/ml was tested using a modified Boyden
chamber assay. The 24hr duration of the experiment employed
was optimal for ligand-induced motility of RPCs as determined
by initial Boyden chamber assay optimization studies spanning
6 to 48hrs. The range of EGF concentrations tested in this
study have previously been shown to drive motility in neuronal
Retinal Progenitor Cell Migration in EGF-gradient
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cell types in Boyden chamber experiments and are relevant to
the retinal microenvironment [24,28,59,60]. Using Dunnett
analysis, significant increases in RPC migration were observed
in 20ng/ml and 40ng/ml experimental conditions compared to
control (n=6 Boyden Chambers each). For each condition,
analysis is reported as normalized mean number of migrated
RPCs, SEM and p-value: 0ng/ml = 1.0000 ± 0.09 (p=1.0000),
20ng/ml =3.0981 ± 0.40 (p=<.0.0001*), 40ng/ml = 2.0340 ±
0.18 (p=0.0001*) and 400ng=1.1885 ± 0.12 (p=0.7816).
Results depicted in Figure 3A show a significant increase in
RPC motility in response to 20ng/ml (p<0.0001) and 40ng/ml
(p=0.0001) of EGF compared to control over 24hrs. In contrast,
there was no significant change in motility of RPCs exposed to
400ng/ml of EGF (Figure 3A). The Boyden chamber results
were independent of RPC growth rates based on MTT
proliferation analysis (Figure 3B). These results support the
IPA interactions network model predictions of EGF-induced
motility of RPCs.
To identify which molecules in the EGF signaling pathway
contribute to RPC motility, inhibition studies were performed
based on signaling pathways identified in initial bioinformatics
analysis at 20ng and 40ng/ml concentrations shown to be
significant in Boyden Chamber studies. RPCs were treated with
inhibitors prior to the 24hr motility assay. We compared RPC
migration from two independent experiments for 20ng/ml
40ng/ml EGF and controls (n=6 chambers each) with each
pharmacologic inhibitor. Statistical significance was determined
using the Dunnett test. For each condition, results are reported
as normalized mean migrated RPC, SEM and p-value: In
20ng/ml condition, no Inhibition = 1.0000 ± 0.08 (p=1.0000),
PD 98059 = 0.7722 ± 0.05 (p=0.1341), AG 490 = 0.5913 ± 0.02
(p=0.0012*), Wortmanin = 0.4699 ± 0.04 (p=<.0001*), Anti-
EGFR = 0.4499 ± 0.10 (p=<.0001*) and AG 1478 = 0.3427 ±
0.06 (<.0001*). At the 20ng/ml level, the majority of inhibitors
effectively reduced migration. RPCs in the 40ng/ml condition
appeared to exhibit a decreased response to selected
inhibitors: in 40ng/ml, no Inhibition = 1.0000 ± 0.09 (p=1.0000),
PD 98059 = 1.5810 ± 0.12 (p=0.0001*), AG 490 = 0.8619 ±
0.04 (p=0.7727) Wortmanin = 0.7779 ± 0.04 (p=0.3368) Anti-
EGFR = 0.4370 ± 0.12 (p=0.0002*) and AG 1478 = 0.9433 ±
0.14 (p=0.9933). To determine if ligand binding to EGFR and
receptor activity influenced observed increases in RPC motility,
we incubated cells with either a monoclonal antibody to EGFR
(anti-EGFR) to inhibit EGF binding to its receptor or a specific
EGFR tyrosine kinase inhibitor (Tyrphostin AG1478) to inhibit
phosphorylation of the receptor cytoplasmic domain (Figure
Figure 1.  EGF Signaling Pathways driving migration of RPCs.  Predicted network of direct molecular interactions influencing
RPC migration in the mammalian retina. The network was generated using Ingenuity Pathway Analysis (IPA) bioinformatics tool.
Molecular components of the EGF signaling pathway are localized to extracellular space, plasma membrane, cytoplasm and
nucleus. Arrows indicate direct interactions between upstream and downstream pathway molecules. Molecule shapes outlined or
filled in red denote significant association with chemotaxis as determined by a right-tailed Fischer test. Molecules displayed on the
left represent key chemical groups predicted to participate indirectly in the network.
doi: 10.1371/journal.pone.0083906.g001
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4A). Our results show that inhibition of ligand binding to EGFR
or receptor tyrosine kinase selectively inhibited motility of RPCs
exposed to 20ng/ml EGF but not to 40ng/ml EGF (Figure 4A).
To determine which downstream signaling pathways were
involved in the EGF-induced motility, we also treated cells with
inhibitors either to STAT3 (AG490), ERK1/2 (PD98059), or
PI3K (Wortmanin). Results in Figure 4A show that inhibition of
the JAK-STAT and PI3K pathways led to a significant reduction
in RPC motility in response to 20ng/ml EGF. A significant
change was not observed in cells treated with 40ng/ml of EGF.
Inhibition of ERK1/2 of the MAPK signaling pathway did not
significantly alter RPC motility in either 20 or 40ng/ml of EGF
(Figure 4A).
Using western blot analysis, the activation states of ERK1/2,
STAT3, and PI3Kinase intracellular proteins in RPCs incubated
in either 20 or 40ng/ml of EGF for 24hr were determined. Our
results show that all three proteins were phosphorylated in
RPCs incubated with 20ng/ml but not 40ng/ml of EGF (Figure
4B). Immunofluorescence results in Figure 2 confirm the
presence of phosphorylated EGFR in RPCs exposed to
20ng/ml. These findings suggest that 20ng/ml EGF optimally
stimulates EGFR tyrosine kinase activity and cell motility in our
RPC population. The intracellular signaling cascades involving
JAK-STAT and PI3K signaling appear necessary for EGF-
induced RPC motility. The central role of ERK1/2-associated
signaling predicted by our model network (Figure 1) may
explain the activated state of the protein in RPCs incubated in
20ng/ml EGF.
Figure 2.  Immunocytochemical localization of RPC total and phosphorylated EGFR expression.  Analysis of EGFR
localization was performed on RPCs isolated from P3-5 transgenic mice expressing green fluorescent protein (GFP) on the actin
promoter (actin-GFP). A) Actin-GFP RPCs express GFP ubiquitously revealing cytoplasm shape of two RPCs in 20ng/ml EGF, B)
Rhodamine bound anti-total EGFR antibody staining reveals robust receptor localization to cell membrane of soma and processes.
C) DAPI labeling of nuclei, D) Overlay of A-C. Panels E-F show identical imaging parameters as A-D, with the exception that F)
utilizes anti-phosphorylated (activated) EGFR labeling. Scale: 10 microns.
doi: 10.1371/journal.pone.0083906.g002
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EGF gradients stimulate chemokinetic migration of
individual RPCs in bridged μ-Lane microfluidic system
analysis
The Boyden chamber assay is best suited for studying
ligand-induced mass movement of cells, as detailed individual
cell migratory dynamics cannot be measured. The Boyden
chamber is comprised of an upper well separated from a lower
well by a micropore filter. Cells are added to the upper well and
chemotactic molecules to the bottom well. Following
incubation, the total number of cells migrated through the
Figure 3.  Boyden Chamber analysis of RPCs to establish optimal physiologic range of EGF concentrations.  The Boyden
chamber provided a high throughput screen to analyze EGF concentrations and exposure times. A) Demonstrates an optimal
physiologic level of EGF, which facilitated significant RPC migration over 24hrs. Analysis of RPCs incubated in Boyden Chambers
containing either 20ng/ml or 40ng/ml EGF revealed significant migration compared to control, 3.0981 ± 0.40 (p=<.0.0001*), 2.0340 ±
0.18 (p=0.0001*) respectively. While 400ng increased migration, this did not result in significant migration above control, 1.1885 ±
0.12 (p=0.7816). Pooled data from n=6 chambers are presented as normalized mean ± SEM. B) Analysis of RPC number following
incubation in each EGF concentration revealed that there was no change in cell proliferation measured via MTT assay.
doi: 10.1371/journal.pone.0083906.g003
Figure 4.  Pharmacologic inhibition of Signaling Pathways Predicted to influence RPC migration.  RPCs were treated with
selected inhibitors of signaling pathways identified in IPA bioinformatics analysis and evaluated for migration over 24hrs using n=6
Boyden Chamber assays per inhibitor. A) Analysis of RPC migration following pre-treatment with selected inhibitors reveal that
significant inhibition of migration was observed in low 20ng EGF condition using anti-EGFR (0.4499 ± 0.10 SEM (p=<.0001*) to
antagonize EGFR cell-surface binding, AG1478 0.3427 ± 0.06 SEM (<.0001*) to inhibit phosphorylation of the EGFR cytoplasmic
domain, AG490 (0.5913 ± 0.02 SEM (p=0.0012*) to inhibit STAT3 activity and Wortmanin (0.4699 ± 0.04 SEM (p=<.0001*) to inhibit
PI3K activity. The use of PD98059 to inhibit ERK1/2 activity did not result in significant inhibition of migration. In the presence of a
higher 40ng/ml concentration of EGF, significant inhibition of migration was observed with anti-EGFR (0.4370 ± 0.12 SEM
(p=0.0002*), while PD98059 1.5810 ± 0.12 SEM (p=0.0001*) increased migration.
Statistical significance was determined using Dunetts analysis and data are presented as normalized mean. B) Robust activation of
identified signaling pathways was observed in 20ng/ml EGF concentrations. Western Blot analysis demonstrated the presence of
both non-phosphorylated (inactivated) and phosphorylated (activated) STAT3, ERK1/2 and P13K proteins RPCs. Inhibition with
significant p-values are denoted with an asterisk.
doi: 10.1371/journal.pone.0083906.g004
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micropores toward the lower well are quantified [47-49,61].
Temporal control and quantitation of stable gradients are
difficult to accomplish in Boyden chamber assays [62]. In
contrast, we are able to show that in a 13mm long, bridged μ-
lane system the concentration of EGF varies in a
mathematically defined manner, is spatially and temporally
quantifiable, and becomes constant for a defined period, once
steady-state gradients are achieved (Figure 5C and [32]). A
number of studies have shown that EGF is capable of
stimulating motility in the form of chemotaxis (directional
migration) and chemokinesis (random migration) [23,24,63].
The employment of the bridged μ-lane system has enabled
time-lapse imaging of individual RPC responses to different
gradients and concentrations of EGF along the microchannel,
providing data to distinguish between chemotactic and
chemokinetic migratory dynamics (Figure 6). After exposing
RPCs to gradients of 20, 40 and 400ng/ml EGF in the
microchannel system, we analyzed accumulated maximum
distance of migration and single cell center of mass (COM)
directionality. COM defines the average point of all cell
endpoints and quantifies migration direction. Analysis of three
independent microfluidic experiments per condition revealed
that RPCs exposed to gradients generated from 20ng/ml EGF
exhibited significantly higher motility including accumulated
maximum micron distances (328.3μm ±109.04 SD) compared
to control channels without EGF (238.4μm ±68.16 SD)
(Dunnett test, p=0.0129) (Figure 7). Accumulated distance
migrated by RPCs in 40ng/ml EGF (237.71μm ± 49.50 SD) and
400ng/ml EGF (293.53μm ± 78.98 SD) microchannel
conditions compared to control did not yield significant
differences, p= 1.0000 and p= 0.1445 respectively. Analysis of
center of mass (COM) of RPCs yielded non-significant
differences in both medians (Brown-Forsythe, p=0.1622) and
means among test groups indicating no significant chemotactic
or directed migration between EGF concentrations compared
to control: 20ng/ml 0.27 ± 54.06 p=0.7965, 40ng/ml 0.21 ±
31.71 p=0.7774 and 400ng/ml 4.00 ± 37.45 p=0.5776 (Figures
6,7). In Figure 6, chemokinetic motility is visualized in trajectory
plots of RPC movement tracked for 24hrs across microfluidic
EGF gradients. In Figure 6, red trajectories depict negative
COM or cell movement away from the EGF source reservoir
while black trajectories depict positive COM or cell movement
towards the source reservoir. Greater multi-directional
displacement of RPCs in the 20ng/ml EGF condition can be
observed in this figure compared to other EGF gradient
conditions. The degree of chemokinetic movement is also seen
to decrease with increasing distance from the EGF source
reservoir. A sample time-lapse video recording corresponding
to the trajectory plot of RPC movement in EGF-gradients
(Figure 6) is shown in movie S1.
Discussion
Bioinformatics Modeling of Signaling Networks
To refine targets from the wide range of biochemical
signaling molecules involved in neural progenitor migration, we
performed bioinformatics analysis using IPA software. Our
bioinformatics-derived network molecules identified two
signaling pathways previously shown to be involved in EGF-
induced motility (Figure 1). Gene network databases have
been used to predict connectivity of genes involved in
chemotactic pathways of migrating adult neural progenitors to
specific lamina [64,65]. Bioinformatics approaches have also
been used to validate molecular network interactions directing
adult neuronal progenitor chemotaxis during neurogenesis in
the sub-ventricular zone and cortex [39,66-68]. In this study,
the bioinformatics predicted EGF signaling network resulted in
valid molecular targets that were shown to influence RPC
motility at the receptor and second-messenger level in Boyden
chamber and microfluidic devices.
Boyden and Microfluidic Approach
Our Boyden analysis demonstrated that EGF stimulates
migration of RPCs at selective uniform concentrations (Figure
3). In Boyden chamber assays, steep gradients of EGF
generated at the start of experiments dissipate and rapidly
become uniform. We utilized Boyden analysis as a high-
throughput screen of multiple concentrations and incubation
times. In contrast, microfluidic analysis provides steady-state
gradients maintained along the length of the microchannel as a
function of time. The bridged µlane system can sustain steady
state concentrations and concentration gradients of ligands
over time spans of 48-96 hours. The double-layered PDMS
design exploits the ultralow bulk velocities generated by density
differences of test ligand concentrations that ensure continuous
one-dimensional transport within the microchannel by
convective diffusion. Numerical simulation of mass transport
within the bridged µlane system combines quantification of 2D
continuity, convective-diffusion, momentum, and hydrostatic
pressure that are computed using the Finite Element Method
[32]. Previously, the microfluidic device has been used to
generate gradient profiles that span over five orders of
magnitude and over time scales that approach the
microenvironments generated in vivo. Microfluidic technology
has proven highly valuable in the creation of biomimetic
microenvironments [32] and has been used to assess
proliferative, survival and differentiation responses of neural
progenitor cells to concentration gradients of extracellular
signaling molecules [27,69]. In this study, live-cell time-lapse
microchannel data was analyzed for maximal accumulated
distance and COM. The data revealed that steady-state EGF
gradients were capable of influencing RPC motility and that
chemokinesis was enhanced at low EGF concentrations
(Figure 6, 7).
RPC Motility is influenced by low EGF ligand
concentrations
Earlier investigations using retinal Muller glia and neurons
revealed that binding of EGF to its receptor is highly specific,
concentration-dependent, and saturates at approximately
80-100ng/ml EGF [19,70,71]. Specificity of EGF binding has
been associated with higher numbers [70] and/or varying states
of EGFRs [40,71]. High and low affinity receptor states differ in
their associations with the EGF ligand, and their activation
differentially influences cellular function [40,70,71]. The number
of high-affinity receptors has been suggested to be 5-10% of
Retinal Progenitor Cell Migration in EGF-gradient
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the total EGFR number [40,58,71]. Similarly, the type and
proportion of EGFRs recruited and activated may differ with
varying concentrations of EGF. Low levels of EGF have been
reported to bind primarily high affinity receptors which trigger
intracellular signaling proteins including Erk, Akt, Shc1, CrkL
and Gab1, while higher concentrations of EGF bind low-affinity
receptors activating PLCγ1 and the Stat proteins [40]. Low- and
high-affinity EGF receptors are derived from the same mRNA
transcript and low affinity receptors can be converted to high
affinity receptors to modify cell response dynamics [40]. Low-
affinity receptor activation has been shown to modify integrin
receptor levels and decrease cell adhesion. EGF
concentrations capable of activating both high and low-affinity
EGF receptors have been shown to facilitate cell motility in vitro
and in vivo [22,23,40]. Our results showing stimulation of RPC
migration at low EGF concentrations of 20ng/ml and 40ng/ml
suggest that the increased motility is mediated in part by high-
affinity receptor signaling. Further analysis could reveal specific
ratios of high and low affinity EGFR dynamics involved in RPC
motility.
RPC Motility is Directed by the EGFR JAK-STAT
Pathway
Our results showing reduced motility of RPCs in response to
steric inhibition of EGFR and chemical inhibition of the receptor
activity strongly suggest the involvement of EGFR and
downstream activity in EGF-induced RPC motility. EGF signal
transduction pathways are shaped by interactions of many
components of signaling networks. A subtle difference in input
signals and/or interaction kinetics may result in differential
response patterns. The kinetics (i.e. the transient and steady-
state behavior) of the cellular response to EGF depends on
many factors, including the number of receptors displayed on
the cell surface; the concentration of the growth factor, docking,
and target proteins; and their initial activity states [72].
Figure 5.  Microfluidic design and modeled gradients of bridged μ-Lane system.  Microfluidic analysis provides precise control
over the establishment and maintenance of chemical concentration gradients. Microfluidic function incorporates fluid dynamics,
molecular diffusivity over time and hydrostatic fluid balance within all parts of the system. A) The microfluidics design includes a
microchannel measuring approximately 13mm (length), 90μm (depth), and 100μm (width), with two reservoirs (source and sink)
defined as the first layer PDMS. A second layer of PDMS, the user interface layer, consists of a bridge channel and two chambers
(source and sink) bonded on top of the first layer forming a fluidic connection between both layers. B) Double-layer PDMS
microfluidic device fabricated after soft lithography and bonding onto glass slides with volume capacities of the chambers and
reservoirs indicated. C) Normalized EGF concentrations plotted against increasing distance from the source reservoir (SRR) to the
sink reservoir (SKR) as a function of time.
doi: 10.1371/journal.pone.0083906.g005
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Moreover, other signaling pathways that share or interact with
one or more components of the EGFR pathway can influence
the kinetic pattern of EGFR signaling [73]. EGF receptors form
either homo- or hetero-dimers following ligand binding, each
dimer showing different affinity for ligands and different
signaling properties. Often, components of different pathways
interact, resulting in complex signaling networks, components
of which are described in Figures 1 and 4. These networks
exhibit emergent properties such as integration of signals
across multiple time scales, generation of distinct outputs
depending on input strength and duration, and self-sustaining
feedback loops. Furthermore, there are slower processes
involving receptor internalization and its subsequent
degradation in lysosomes, which have an important role in
Figure 6.  Trajectory analysis paradigm for RPC migration in microfluidic gradients at increasing distances from the EGF
source.  Positional tracking of RPCs migrating in steady state gradients of EGF generated in a 13mm bridged μ-lane device over a
24hr period was visualized using Ibidi Migration software to generate wind-rose plots (A-D). A) Cell tracking results are depicted at
increasing distances from the source reservoir: 0-500μm (I), 2000-3500μm (II), 5000-7000μm (III). B-D) Depiction of RPC trajectory
plot mapping in steady-state gradients of 20, 40, and 400ng/ml EGF analyzed from source reservoirs to sink reservoirs. A trend of
reduced chemokinetic migratory dynamics can be observed with increasing EGF concentrations up to 400ng/ml. Red and black
traces indicate RPCs with negative and positive COM, respectively.Statistics resulting from trajectory data depicted here analyzed
for maximum distance and center of mass are reported below. The x- and y-axis denote RPC displacement in horizontal and vertical
directions, respectively.
doi: 10.1371/journal.pone.0083906.g006
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EGF-induced signaling [72,74]. In this study, RPCs stimulated
with 20ng/ml of EGF expressed activated forms of EGFR,
ERK1/2, STAT3 and PI3K. Analysis of Inhibition of individual
downstream signaling pathways suggests that EGF-stimulated
motility involves the JAK-STAT and PI3K pathways and not the
ERK1/2 pathway. These findings suggest differential activation
and inhibition of canonical EGF signaling pathways. Additional
studies could explore additional factors involved in EGF
signaling including multiple interacting ligands; receptor
density/degradation and overlapping signaling network
dynamics.
RPCs Show Chemokinetic Migratory Response in low
nanomole EGF Microfluidic Gradients
To study the mode of individual RPC migration in response
to defined EGF gradients we utilized engineered microfluidic
devices. Defined steady-state gradients generated using
microfluidics provide mathematically modeled, quantitative
information about ligand concentrations in a controlled
environment. By carefully choosing the concentration of the
input, a wide variety of gradient steps and concentration ranges
can be created in microfluidic devices [62]. Applying a 20ng/ml
EGF media concentration in the bridged μ-lane device
stimulated the greatest chemokinetic responses at regions
closest to the source reservoir (SRR), where the chemical
gradient is steepest (Figure 5). The ligand concentration at
18hrs in the region of the channel closest to the SRR is
approximately 63% of the starting EGF concentration [28]
suggesting that RPCs respond to steep gradients of low EGF
concentrations. The results are supported by several studies
describing saturating effects of EGF in signal transduction and
motility [28,40,70]. Our study is the first demonstration of the
effect of controlled gradients on RPC motility in vitro.
Future Work
Findings from this study defining EGF receptor ligand
interactions and emergent motility dynamics may be useful
towards developing in vitro models of endogenous signaling
guiding transplanted RPC motility in vivo. Sub-retinally
transplanted RPCs migrate through the interphotoreceptor
matrix to reach appropriate retinal lamina for repair. To
accurately model RPC migration, future microfluidics studies
may replicate the topological and biochemical properties of the
interphotoreceptor matrix by employing three-dimensional
biomimetic extracellular matrix gel composed of laminin,
fibronectin and collagen proteins as well as chondroitin sulfate
proteoglycans and glycosaminoglycans [75,76]. An ECM
substrate available for initial testing is MaxGel, and engineered
hydrogels can be covalently modified with chondroitin and
heparin-sulfate proteoglycans and peptides [77,78].
Transparent synthetic ECM matrices form porous soft gels
along the length of the microchannel, allowing formation of a
chemical gradients and visual tracking for quantitative
assessment of cell morphology and motility. A number of
recent studies have shown that stem and progenitor cells
cultured in 3D gels attach to and remodel their extracellular
matrix environments allowing for proliferative and migratory
dynamics comparable to those observed in vivo [79-81]. The
use of 3D gels to mimic the retinal microenvironment could
enhance future in vitro models analyzing RPC motility.
Figure 7.  Analysis of RPC maximum accumulated distance and center of mass dynamics in microfluidic bridged μ-lane
EGF gradients.  A) RPC maximum displacement was analyzed in the absence or presence of varying EGF gradients measured
post-steady-state within a 24hr period, and results are expressed as mean ± standard deviation for three independent studies per
EGF concentration. Only RPCs cultured in 20ng/ml EGF exhibited significantly higher maximum displacement compared to cells in
the control microchannel (328.26 ± 109.04, p=0.0166), Dunnett Test. B) Similar measurements for center of mass (COM) of RPCs
yielded non-significant differences in both means and medians among test groups (Brown-Forsythe, p=0.1622) indicating no
significant chemotactic or directed migration between EGF concentrations. This reveals that the increased Maximum accumulated
distance response can be defined as chemokinetic. C) displays averaged maximum distance accumulated and COM of RPCs in
defined EGF concentration gradients with their respective standard deviation and p-values results from the Dunnett statistical test.
Significant p-values are denoted with an asterisk.
doi: 10.1371/journal.pone.0083906.g007
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In summary, we present experimental work showing a mode
of migration of RPCs in microfluidic environments, which was
previously not described. We demonstrate that EGFR
activation of downstream JAK-STAT signaling pathways in our
population of RPCs is optimal at low EGF concentrations. The
inhibition of these pathways results in inhibition of migration. In
addition live-cell imaging of RPCs in defined chemical
gradients demonstrates that EGF induces chemokinetic
migratory dynamics. This work represents an important step in
the analysis of transplantable RPC populations in physiologic
concentrations comparable to those found in developing and
disease retina [17]. The data presented here provides a model
of stem and progenitor cell migratory analysis to inform future
transplantation strategies.
Supporting Information
Movie S1.  Time-lapse microscopy of RPC migratory
response to EGF in a microfluidic channel. Live-cell images
were obtained at hourly intervals over 24hrs. GFP+-RPC
fluorescence was detected using a CCD camera coupled to a
Nikon Ti microscope with Elements software. Visualized RPC
migratory trajectories were then quantified for accumulated
distance and center of mass motility.
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